Focus and Scope
The “Diabetes Mellitus” is a peer-reviewed research and clinical journal published quarterly since 1998 under the auspices of Russian Association of Endocrinologists and Federal Endocrinology Research Centre (Moscow).
Its content focuses on original papers on clinical, experimental and academic studies, but also includes literature reviews, lectures, case studies and supplementary materials. General discourse of the journal is dedicated to the key aspects of diabetology, encompassing etiology, epidemiology and pathogenesis of diabetes mellitus, novel diagnostic and therapeutic methods, as well as prevention and management of acute and late complications of diabetes mellitus and associated conditions.
The intended primary audience of the journal is medical professionals (including diabetologists, endocrinologists, general practitioners, family physicians and pediatricians), scientists and academicians working in the area of endocrinology and diabetology.
In 2014 “Diabetes Mellitus” has become fully bilingual, now featuring full-text English versions of all published materials, and adopted the Gold Open Access distribution model.
The current editorial board understanding of the journal’s mission is as following:
- to facilitate the exchange of clinical experience and scientific data between Russian-speaking and international diabetology communities;
- to inform Russian-speaking medical professionals about the relevant and high-quality evidence-based clinical data.
The journal publishes reviews of literature, including systematic reviews of clinical trials in different directions of diabetess mellitus and related areas.
The main purpose of a review manuscript should be a discussion of actual data or presentation the original author's view on a problem. It shouldn't be a simple enumeration of previously published data. Thus, the discussion is a mandatory part of the review manuscript (it can be isolated in a separate section or place systematically throughout the text).
Authors should indicate all the sources of primary information in the manuscript (names of the full-text and references databases, keywords and other search settings).The manuscript of literature review should be structured into sections and contain graphic materials.
|Open Submissions||Indexed||Peer Reviewed|
The journal accept manuscript containing results of international and local clinical and experimental studies, and meta-analyzes in the area of diabetology and related specialties.
The journal is welcome for manuscripts with human subjects studies results, as well as results of experimental studies in vitro and animal studies. Journal does not publish experimental and clinical studies of dietary supplements ("bioactive adds to food").
Editorial board will select for publication only manuscropts of clinical and experimental studies which were conducted in accordance with international biomedical ethics and deontology principles. Editorial board asks the authors to describe that presented study was conducted in accordance with international GCP standards: voluntary signing of an informed consent by all of participants; approval of the study protocol by the local ethics committee (the distinct name of ethics committee, the meeting date and protocol number should be indicate in a manuscript), etc.
The detailed study protocol should be presented in the manuscript. Authors should give so many details of a study protocol as need for it fully replaying. In the case of meta-analyze authors should describe in details the procedure of information search: names of databases, filters and keywords, as well as any additional search settings for primary sources collecting.
In compliance with the ethics policy editorial board asks authors to indicate the source of funding of their work (study preparation, writing and publishing the manuscript, etc.), and declare of apparent or potential conflicts of interests. Please note that the presence of obvious or potential conflict of interest (including the financial interest of the authors) or affiliation of any organization (public or private) with conduction of the research is not a reason for a manuscript rejection. Rather, it gives additional advantages of manuscript under evaluation by reviewers and will cause more interest and trust from readers.
|Open Submissions||Indexed||Peer Reviewed|
The journal is looking for manuscripts with case reports in the area of diabetology and related specialties.
Potential topics for case reports are:
- diagnosis - new or rare diabetes-related condition or unusual presentation of common condition, uncertain diagnosis situation, discussion of differential diagnoses, novel diagnostic procedures;
- treatment - new treatments or established treatments in new situations, treatment of rare diabetes-related conditions, unique technical procedures, unexpected outcomes or effects from routine or rare procedures, adverse events or unanticipated events;
- special circumstances - highly individualized treatments, complex situations, integration of multiple therapies, ethical challenges, learning from errors, findings that shed new light on the possible pathogenesis of a disease or an adverse effect.
The main purpose of a manuscript should be a clinical case presentation in view of diagnostic approach, ethical or management challenge, or highlights new aspects of pathogenesis, pharmacology or histopathology. Manuscript should discuss accumulated facts and also compare new data with previously proven information.
We recommend all authors to hold the manuscript structure and chronologize all the facts, report common information about the patient’s disease. In case your manuscript is devoted to treatment challenge, describe the medication, its indications and usage specifications also with any potential side effects. A summary of data on the topic may be also presented. Briefly summarize the background of this case report. Describe the patient characteristics (such as the relevant demographics — age, gender, ethnicity, occupation) and their presenting concerns with relevant details of related past interventions. Also, present the medical, family, and psychosocial history including lifestyle and genetic information, other pertinent co-morbidities and interventions (other therapies including self-care).
Data structure for a case report should include the following sections:
- symptoms of the disorder;
- physical examination focused on the important findings including results from testing;
- diagnostic methods (including laboratory testing, imaging results, questionnaires, referral diagnostic information);
- diagnostic challenges (such as limited ability to complete an evaluation, patient availability, cultural) and diagnostic reasoning including other diagnoses considered;
- interventions (such as pharmacologic, surgical, preventive, lifestyle, self-care);
- administration and intensity of the intervention (including dosage, strength, duration, frequency);
- prognostic characteristics.
Please describe the strengths and limitations of this case report including case management, and the scientific and medical literature related to this case report. Discuss the rationale for your conclusions such as potential causation and the ways this case might be generalized to a larger population. Finally, what are the main findings of this case report and what are the 'take-away' messages?
|Open Submissions||Indexed||Peer Reviewed|
Peer Review Process
A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of “Diabetes mellitus”. This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer.
- Members of the editorial board and leading Russian and international experts in corresponding areas of life sciences, invited as independent readers, perform peer reviews. Editor-in-chief, deputy editor-in-chief or science editor choose readers for peer review. We aim to limit the review process to 2-4 weeks, though in some cases the schedule may be adjusted at the reviewer’s request.
- Reviewer has an option to abnegate the assessment should any conflict of interests arise that may affect perception or interpretation of the manuscript. Upon the scrutiny, the reviewer is expected to present the editorial board with one of the following recommendations: to accept the paper in its present state; to invited the author to revise their manuscript to address specific concerns before final decision is reached; that final decision be reached following further reviewing by another specialist; to reject the manuscript outright.
- If the reviewer has recommended any refinements, the editorial staff would suggest the author either to implement the corrections, or to dispute them reasonably. Authors are kindly required to limit their revision to 2 months and resubmit the adapted manuscript within this period for final evaluation.
- We politely request that the editor be notified verbally or in writing should the author decide to refuse from publishing the manuscript. In case the author fails to do so within 3 months since receiving a copy of the initial review, the editorial board takes the manuscript off the register and notifies the author accordingly.
- If author and reviewers meet insoluble contradictions regarding revision of the manuscript, the editor-in-chief resolves the conflict by his own authority.
- The editorial board reaches final decision to reject a manuscript on the hearing according to reviewers’ recommendations, and duly notifies the authors of their decision via e-mail. The board does not accept previously rejected manuscripts for re-evaluation.
- Upon the decision to accept the manuscript for publishing, the editorial staff notifies the authors of the scheduled date of publication.
- Kindly note that positive review does not guarantee the acceptance, as final decision in all cases lies with the editorial board. By his authority, editor-in-chief rules final solution of every conflict.
- Original reviews of submitted manuscripts remain deposited permanently (not less than 5 years).
- Manuscript reviews are not published. Reviews can be sent to the Ministry of Education and Sciense of Russian Federation in case of query.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles in "Diabetes Mellitus" journal are indexed by several systems:
- Russian Science Citation Index (RSCI) by “Electronic Scientific Library” foundation (elibrary.ru)
- Directory of Open Access Jurnals (DOAJ)
- Scopus (Elsevier)
- Google Scholar
- Ulrich's Periodicals Directory
The Ethic policy of "Diabetes Mellitus" journal is based on recomendations from international commettees:
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
Review and professional publication articles should also be accurate and objective, and editorial opinion works should be clearly identified as such.
Data Access and Retention
Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.
Originality and Plagiarism
Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable.
Only original works are acceptable for publication in "Diabetes Mellitus" journal. The journal does not allow any forms of plagiarism.
If the authors have used the work and/or words of others, that this has been appropriately cited or quoted.
The journal is using "ANTIPLAGIAT" (free edition) software for plagiarism detection in all Russian-language manuscripts. The Google Scholar is used for English-language manuscripts. Papers will be rejected from any stage of the publication process(even if the article were published already) if plagiarism will be fined.
Papers will be rejected from any stage of the publication process (even if the article were publishedalready) if plagiarism will be fined.
Multiple, Redundant or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.
In general, an author should not submit for consideration in another journal a previously published paper. Publication of some kinds of articles (eg, clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Further detail on acceptable forms of secondary publication can be found at http://www.icmje.org/
Acknowledgement of Sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.
Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.
The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
Hazards and Human or Animal Subjects
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
Statement of Human and Animal Rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.
When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest stage possible.
Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the authors obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper. If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.
The page is based on original materials from the Elsevier: http://cdn.elsevier.com/promis_misc/ethicalguidelinesforauthors.pdf
Publication in "Diabetes Mellitus" journal is free for all authors.
The "Diabetes Mellitus" journal charge no publication fees for authors - including those of peer-review management, manuscript processing, journal production, Open-Access, online hosting and archiving.